Can we give inj human actrapid intramuscular
Reading File
Finding Sources
Searching the Web
human actrapid insulin intramuscular injection route of administration
Reading File
Reading File
Here is a complete, authoritative answer on this topic:
Can Human Actrapid (Regular Insulin) Be Given Intramuscularly?
Yes - with important caveats.
What the textbooks say
Goodman & Gilman's Pharmacological Basis of Therapeutics states clearly:
"Regular, unbuffered, 100-units/mL insulin also may be given intravenously or intramuscularly."
Critical concentration caveat: The 500 units/mL concentrated formulation is for subcutaneous injection ONLY and must NOT be given IM or IV.
Since Actrapid comes as 100 IU/mL, it is the formulation that CAN be given IM.
When is IM insulin used?
Rosen's Emergency Medicine notes:
"In selected patients with mild DKA, the subcutaneous or intramuscular administration of insulin has been proven safe and effective as IV administration of insulin."
It is used in:
- Mild DKA when IV access is not available
- Emergency settings as a temporizing measure
- Patients who are well-hydrated with mild acidosis
Why IM is generally avoided (preferred routes are SC or IV)
| Factor | IM Route |
|---|---|
| Absorption | Faster than SC, but unpredictable |
| Blood flow dependency | Yes - poor perfusion (shock, dehydration) impairs IM absorption significantly |
| FDA approval | Not approved by the FDA for IM use (Tintinalli's Emergency Medicine) |
| Risk in sick patients | Erratic absorption makes it unreliable in severely ill/hypoperfused patients |
As Rosen's points out: "Poor perfusion may hamper the absorption of intramuscular or subcutaneous insulin, resulting in erratic absorption, making IV infusion the route of choice in sicker DKA patients."
Bottom line
- Actrapid 100 IU/mL CAN be given IM - it is pharmacologically acceptable and used in selected clinical situations (mild DKA, emergency use).
- It is not FDA-approved for IM use and is not the preferred route.
- IV infusion remains the gold standard in hospital settings; SC is the standard for routine diabetes management.
- Never give the 500 IU/mL concentrated insulin IM or IV.
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Rosen's Emergency Medicine; Tintinalli's Emergency Medicine.
What are the specific dosing regimens for IM insulin in emergency situations?
Finding Sources
Searching PubMed
intramuscular insulin DKA dosing regimen
Finding Sources
Searching PubMed
intramuscular insulin diabetic ketoacidosis
Finding Sources
Reading Article
PMID: 406561
Reading Article
PMID: 29026743
Reading File
Reading File
Finding Sources
Finding Sources
Searching the Web
intramuscular regular insulin DKA dosing protocol 0.1 units/kg loading dose clinical guideline
Here is a comprehensive breakdown of IM insulin dosing in emergency situations, synthesized from textbooks, clinical guidelines, and trial data:
IM Insulin Dosing Regimens in Emergency Settings
When is IM insulin considered?
IM regular insulin is used only when IV access is unavailable or not feasible, primarily in:
- Mild to moderate DKA (not severe DKA with shock/poor perfusion)
- Low-resource or primary care/field settings
- As a bridge until IV access is established
Standard IM Dosing Protocol for DKA
The best-studied regimen (from AAFP guidelines and the landmark Fisher et al. RCT, NEJM 1977):
| Phase | Dose | Notes |
|---|---|---|
| Loading/priming dose | 0.3 units/kg total - half IV bolus + remainder IM or SC | Used when IV available but IM chosen for maintenance |
| If no IV access | 0.1-0.2 units/kg IM as initial dose | Given into deltoid or thigh |
| Maintenance | 0.1 units/kg/hour IM | Repeated hourly until glucose ~250 mg/dL |
| Target glucose fall | 75-90 mg/dL per hour | If no fall in first hour, re-dose or seek IV access |
Harrison's Principles of Internal Medicine (22nd ed.) recommends for mild-moderate DKA:
"Subcutaneous rapid-acting insulin may be used with close monitoring (0.1 unit/kg rapid-acting insulin analogue subcutaneously and then 0.1 unit/kg every 1 h or 0.2 unit/kg every 2 h)."
The same weight-based logic applies to IM dosing with regular insulin.
Real-world IM Protocol (Low-Resource Setting)
A 2017 Indian study (PMID 29026743) in family medicine units managing 34 DK/DKA patients with IM regular insulin reported:
- Mean time to reduce glucose to < 250 mg/dL: ~3.8-3.9 hours
- Mean total insulin used to correct acidosis: ~72.3 units over ~33 hours
- Only 1 hypoglycemia event, no fatalities
- Conclusion: "IM regular insulin is a safe alternative method in managing DK and DKA in a family medicine setting"
Key Preconditions Before Starting IM Insulin
These are non-negotiable regardless of route:
- Check potassium first - Do NOT give insulin if K+ < 3.3 mEq/L (risk of fatal arrhythmia). Replete potassium first.
- Adequate hydration - IM absorption is unreliable in dehydrated/hypoperfused patients. IV fluids (0.9% NaCl 1-2 L) must be started first.
- Mild-moderate DKA only - Severe DKA (pH < 7.0, altered consciousness, shock) requires IV infusion.
- Glucose monitoring - Every 1-2 hours mandatory; switch to IV if glucose not falling.
IM vs IV vs SC - Comparative Evidence
The Fisher et al. NEJM RCT (PMID 406561) randomized 45 DKA patients to IV, SC, or IM insulin:
- IV had a faster fall in glucose and ketones in the first 2 hours (p < 0.01)
- After 2 hours, no significant difference between routes in rate of glucose/ketone decline
- IM required repeat priming doses more often (6/15 patients vs 2/15 IV)
- Conclusion: "The optimal route of insulin administration is by initial intravenous combined with subcutaneous or intramuscular"
When to Switch from IM to IV
Switch to IV infusion if:
- Patient is hypotensive or in shock (poor perfusion)
- Glucose is NOT falling by 10% after 1 hour
- Patient deteriorates clinically
- Severe DKA criteria met (pH < 7.0, HCO3 < 10, altered mental status)
Bottom line: IM insulin in DKA follows a 0.1 units/kg loading dose then 0.1 units/kg/hour regimen, given only in mild-moderate DKA in well-hydrated patients with confirmed adequate potassium. IV remains the gold standard. - Harrison's 22nd ed.; Symptom to Diagnosis 4th ed.; AAFP DKA Guidelines
This is a shared conversation. Sign in to Orris to start your own chat.